These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 10426869)
1. What do new lytics add to t-PA? Van de Werf F Am Heart J; 1999 Aug; 138(2 Pt 2):S115-20. PubMed ID: 10426869 [TBL] [Abstract][Full Text] [Related]
2. Low-dose fibrinolytics and glycoprotein IIb/IIIa receptor blockade for the treatment of acute myocardial infarction. Ferrario M; Repetto A; Lucreziotti S; Ardissino D Am Heart J; 1999 Aug; 138(2 Pt 2):S121-5. PubMed ID: 10426870 [No Abstract] [Full Text] [Related]
3. IIb/IIIa receptor blockade in acute myocardial infarction. Ferguson JJ; Taqi K Am Heart J; 1999 Aug; 138(2 Pt 2):S164-70. PubMed ID: 10426877 [TBL] [Abstract][Full Text] [Related]
4. Advances in antithrombotic therapy of acute myocardial infarction. Gensini GF; Comeglio M; Falai M Am Heart J; 1999 Aug; 138(2 Pt 2):S171-6. PubMed ID: 10426878 [TBL] [Abstract][Full Text] [Related]
5. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial. Topol EJ; Lancet; 2001 Jun; 357(9272):1905-14. PubMed ID: 11425410 [TBL] [Abstract][Full Text] [Related]
6. Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies. Waters RE; Mahaffey KW; Granger CB; Roe MT Am Heart J; 2003 Dec; 146(6):958-68. PubMed ID: 14660986 [TBL] [Abstract][Full Text] [Related]
7. Conjunctive use of platelet glycoprotein IIb/IIIa antagonists and thrombolytic therapy for acute myocardial infarction. Moliterno DJ; Topol EJ Thromb Haemost; 1997 Jul; 78(1):214-9. PubMed ID: 9198156 [No Abstract] [Full Text] [Related]
8. Increased reperfusion by glycoprotein IIb/IIIa receptor antagonist administration in case of unsuccessful and failed thrombolysis in patients with acute myocardial infarction: a pilot study. Di Pasquale P; Sarullo FM; Cannizzaro S; Vitrano MG; Giubilato A; Scalzo S; Giambanco F; Paterna S Ital Heart J; 2001 Oct; 2(10):751-6. PubMed ID: 11721719 [TBL] [Abstract][Full Text] [Related]
9. The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends. Campbell KR; Ohman EM; Cantor W; Lincoff AM Am J Cardiol; 2000 Apr; 85(8A):32C-8C. PubMed ID: 10793178 [TBL] [Abstract][Full Text] [Related]
10. Primary stenting and glycoprotein IIb/IIIa inhibitors in acute myocardial infarction. Colombo A; Briguori C Am Heart J; 1999 Aug; 138(2 Pt 2):S153-7. PubMed ID: 10426875 [TBL] [Abstract][Full Text] [Related]
11. Do new devices add to the results of PTCA in acute myocardial infarction? Moses J; Moussa I Am Heart J; 1999 Aug; 138(2 Pt 2):S158-63. PubMed ID: 10426876 [TBL] [Abstract][Full Text] [Related]
12. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis]. Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194 [TBL] [Abstract][Full Text] [Related]
13. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators. Ohman EM; Kleiman NS; Gacioch G; Worley SJ; Navetta FI; Talley JD; Anderson HV; Ellis SG; Cohen MD; Spriggs D; Miller M; Kereiakes D; Yakubov S; Kitt MM; Sigmon KN; Califf RM; Krucoff MW; Topol EJ Circulation; 1997 Feb; 95(4):846-54. PubMed ID: 9054741 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy for acute myocardial infarction: fibrinolytic therapy and glycoprotein IIb/IIIa inhibition. Califf RM Am Heart J; 2000 Feb; 139(2 Pt 2):S33-7. PubMed ID: 10650314 [TBL] [Abstract][Full Text] [Related]